Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-28
2011-06-28
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S349000, C514S212030, C540S527000, C546S297000, C548S550000
Reexamination Certificate
active
07968592
ABSTRACT:
3-aminopyrrolidone compounds and pharmaceutically acceptable salts thereof that are active as sodium and/or calcium channel modulators and therefore useful in preventing, alleviating and curing a wide range of pathologies, including, but not limited to cardiovascular, inflammatory, ophthalmic, urologic, metabolic and gastrointestinal diseases.
REFERENCES:
patent: WO 97/05111 (1997-02-01), None
patent: WO 99/35123 (1999-07-01), None
patent: WO 99/35125 (1999-07-01), None
patent: WO 03/057219 (2003-07-01), None
Suzuki et al. (JP 01204073 A, Aug. 16, 1989; see attached CAS Abstract and structure).
Ragsdale et al. (Brain Research Reviews 1998, 26, 16-28).
Leong et al. (Pain Medicine 2001, 2(3), 228-229).
Sica, D.A. (The Journal of Clinical Hypertension 2006, 8(1), 53-56).
Sabido-David (Expert. Opinion Investig. Drugs 2004, 13(10), 1249-1261).
Priest et al. (PNAS 2007, 104(20), 8205-06).
Brown et al. Environmental Health Perspectives 2005, 113(9), 1250-1256.
Sydney-Smith's presentation: Neurodegenerative Disease, at the International Summit for Mental Health, Mar. 2009.
Fischer et al. Neurodegenerative Diseases 2004, 1, 50-70.
Database Chemcats Chemical Abstracts Service, Columbus, Ohio, US; XP002269487, Order No. CGX-0154580 & “Comgenex Product List”, Jun. 26, 2003, Comgenex International, Inc, Monmouth Jct., NJ, 08852 USA.
Maestroni Sara
Raveglia Luca Francesco
Sabido David Cibele Maria
Salvati Patricia
Thaler Florian
Anderson Rebecca L
Newron Pharmaceuticals S.p.A.
Nolan Jason M
Young & Thompson
LandOfFree
3-aminopyrrolidone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-aminopyrrolidone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-aminopyrrolidone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2621756